Related Experiment Video
Updated: Jun 13, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Modulation of sarcoplasmic reticulum Ca(2+) cycling in systolic and diastolic heart failure associated with aging
Andrzej M Janczewski1, Edward G Lakatta
1janczewskia@upmc.edu
Insights
Aging significantly worsens cardiovascular disease, including heart failure (HF). Key changes in cardiac cells involve altered calcium handling and signaling, impacting heart function in older individuals.
Area of Science:
- Cardiovascular Science
- Gerontology
- Molecular Cardiology
Background:
- Cardiovascular diseases like hypertension and atherosclerosis disproportionately affect older populations, with age being a primary risk factor.
- Aging leads to detrimental changes in cardiac cell function, including impaired beta-adrenergic receptor (ss-AR) signaling and increased oxidative stress.
- These cellular changes contribute to the worsening prognosis of cardiovascular conditions in the elderly.
Purpose of the Study:
- To review age-associated alterations in cardiac calcium (Ca2+) handling proteins and their functional consequences.
- To explore the role of sarcoplasmic reticulum (SR) Ca2+ transport, sarcolemmal channels, and exchangers in cardiac aging.
- To discuss sexual dimorphism and cardiac self-renewal in the context of aging and heart failure.
Main Methods:
- Literature review focusing on age-related changes in cardiovascular physiology.
- Analysis of studies investigating cardiac myocyte and organ-level functional consequences of aging.
- Examination of research on calcium-transporting proteins, ss-adrenergic receptors, and reactive oxygen species (ROS) in aging hearts.
Main Results:
- Aging impairs ss-adrenergic receptor (ss-AR) signaling, increases reactive oxygen species (ROS) generation, and alters excitation-contraction (EC) coupling.
- Key changes include prolonged action potential (AP), delayed intracellular Ca2+ (Ca(i)(2+)) transient, and blunted force-frequency responses.
- Altered sarcoplasmic reticulum (SR) Ca2+ uptake, storage, and release are central to these age-related cardiac dysfunctions, involving L-type Ca2+ channels (LCC) and Na+-Ca2+ exchangers (NCX).
Conclusions:
- Age-related changes in Ca2+ handling proteins significantly impact cardiac myocyte and organ function.
- Understanding these mechanisms is crucial for addressing the epidemic of cardiovascular disease in older adults.
- Further research into sexual dimorphism and cardiac regeneration may offer new therapeutic avenues for age-related heart failure.
Abstract:
Hypertension, atherosclerosis, and resultant chronic heart failure (HF) reach epidemic proportions among older persons, and the clinical manifestations and the prognoses of these worsen with increasing age. Thus, age per se is the major risk factor for cardiovascular disease. Changes in cardiac cell phenotype that occur with normal aging, as well as in HF associated with aging, include deficits in ss-adrenergic receptor (ss-AR) signaling, increased generation of reactive oxygen species (ROS), and altered excitation-contraction (EC) coupling that involves prolongation of the action potential (AP), intracellular Ca(2+) (Ca(i)(2+)) transient and contraction, and blunted force- and relaxation-frequency responses. Evidence suggests that altered sarcoplasmic reticulum (SR) Ca(2+) uptake, storage, and release play central role in these changes, which also involve sarcolemmal L-type Ca(2+) channel (LCC), Na(+)-Ca(2+) exchanger (NCX), and K(+) channels. We review the age-associated changes in the expression and function of Ca(2+) transporting proteins, and functional consequences of these changes at the cardiac myocyte and organ levels. We also review sexual dimorphism and self-renewal of the heart in the context of cardiac aging and HF.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy

